newdrugapprovals.org
Long-term use of AZ’ Brilinta, ticagrelor gets US priority review
An application to use AstraZeneca’s Brilinta to treat patients with a history of heart attack has been placed on a fast track regulatory pathway in the US, meaning that approval could be gra…